Logo image of LGND

LIGAND PHARMACEUTICALS (LGND) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:LGND - US53220K5048 - Common Stock

206.65 USD
+6.59 (+3.29%)
Last: 1/9/2026, 8:00:02 PM
206.6 USD
-0.05 (-0.02%)
Pre-Market: 1/12/2026, 4:40:47 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LGND revenue by date.LGND revenue by date.
196.2M
-29.20%
131.314M
-33.07%
167.133M
27.28%
255.49M
52.87%
270.99M
6.07%
319.3M
17.83%
377.52M
18.23%
416.81M
10.41%
499.38M
19.81%
613.14M
22.78%
746.83M
21.80%
EBITDA
YoY % growth
LGND ebitda by date.LGND ebitda by date.
54.5M
-58.08%
46.342M
-14.97%
58.26M
25.72%
108.82M
86.78%
181.5M
66.79%
234.59M
29.25%
222.53M
-5.14%
259.58M
16.65%
306.06M
17.91%
N/AN/A
EBIT
YoY % growth
LGND ebit by date.LGND ebit by date.
3M
-96.20%
9.821M
227.37%
23.021M
134.41%
50.211M
118.11%
132.17M
163.23%
168.45M
27.45%
169.32M
0.52%
187.49M
10.73%
262.18M
39.84%
337.99M
28.92%
420.68M
24.47%
Operating Margin
LGND operating margin by date.LGND operating margin by date.
1.53%7.48%13.77%19.65%48.77%52.76%44.85%44.98%52.50%55.12%56.33%
EPS
YoY % growth
LGND eps by date.LGND eps by date.
4.28
-33.33%
6.10
42.52%
5.71
-6.39%
7.46
30.63%
8.41
12.81%
9.81
16.58%
11.34
15.63%
11.62
2.47%
14.74
26.81%
16.83
14.19%
18.40
9.33%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.59
25.00%
1.92
44.26%
1.89
18.43%
2.35
-23.99%
2.51
58.06%
Revenue
Q2Q % growth
56.336M
31.59%
61.339M
35.31%
64.876M
36.22%
73.238M
-15.71%
77.436M
37.45%
EBITDA
Q2Q % growth
35.966M
-2.60%
48.51M
273.94%
49.39M
82.84%
57.976M
-27.22%
63.059M
75.33%
EBIT
Q2Q % growth
22.266M
1,219.86%
50.483M
237.71%
42.668M
338.97%
46.512M
-14.02%
N/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
3.09
67.93%
1.961.1357.31%
Q2 2025
Q2Q % growth
1.60
14.29%
1.450.1510.36%
Q1 2025
Q2Q % growth
1.33
10.83%
1.240.097.61%
Q4 2024
Q2Q % growth
1.27
-7.97%
1.210.064.63%
Q3 2024
Q2Q % growth
1.84
80.39%
1.370.4733.98%
Q2 2024
Q2Q % growth
1.40
-1.41%
1.080.3229.98%
Q1 2024
Q2Q % growth
1.20
-47.37%
0.790.4150.98%
Q4 2023
Q2Q % growth
1.38
1.47%
0.670.71104.76%
Q3 2023
Q2Q % growth
1.02
-22.14%
0.620.4063.93%
Q2 2023
Q2Q % growth
1.42
37.86%
0.650.77117.61%
Q1 2023
Q2Q % growth
2.28
293.10%
0.911.37150.03%
Q4 2022
Q2Q % growth
1.36
-24.44%
1.220.1411.74%
Q3 2022
Q2Q % growth
1.31
-17.09%
0.440.87197.43%
Q2 2022
Q2Q % growth
1.03
-36.81%
0.440.59134.84%
Q1 2022
Q2Q % growth
0.58
-58.87%
0.67-0.09-13.41%
Q4 2021
Q2Q % growth
1.80
11.11%
1.400.4028.81%
Q3 2021
Q2Q % growth
1.58
51.92%
1.060.5249.42%
Q2 2021
Q2Q % growth
1.63
63.00%
1.390.2417.36%
Q1 2021
Q2Q % growth
1.41
58.43%
1.150.2622.88%
Q4 2020
Q2Q % growth
1.62 1.010.6160.43%
Q3 2020
Q2Q % growth
1.04 1.000.043.86%
Q2 2020
Q2Q % growth
1.00 0.780.2228.97%
Q1 2020
Q2Q % growth
0.89 0.670.2232.87%
LGND Yearly EPS VS EstimatesLGND Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
86.892M
67.71%
59.971M26.921M44.89%
Q2 2025
Q2Q % growth
47.627M
14.68%
44.747M2.88M6.44%
Q1 2025
Q2Q % growth
45.333M
46.34%
39.476M5.857M14.84%
Q4 2024
Q2Q % growth
42.812M
52.35%
39.803M3.009M7.56%
Q3 2024
Q2Q % growth
51.812M
57.64%
41.463M10.349M24.96%
Q2 2024
Q2Q % growth
41.531M
57.52%
33.522M8.009M23.89%
Q1 2024
Q2Q % growth
30.978M
-29.56%
28.482M2.496M8.76%
Q4 2023
Q2Q % growth
28.101M
3.89%
26.23M1.871M7.13%
Q3 2023
Q2Q % growth
32.868M
-44.50%
27.73M5.138M18.53%
Q2 2023
Q2Q % growth
26.366M
-54.08%
26.248M118K0.45%
Q1 2023
Q2Q % growth
43.979M
20.42%
34.718M9.261M26.67%
Q4 2022
Q2Q % growth
27.05M
-62.67%
39.952M-12.902M-32.29%
Q3 2022
Q2Q % growth
59.22M
-8.67%
39.043M20.177M51.68%
Q2 2022
Q2Q % growth
57.42M
-32.19%
38.489M18.931M49.19%
Q1 2022
Q2Q % growth
36.52M
-33.78%
37.052M-532K-1.44%
Q4 2021
Q2Q % growth
72.47M
3.54%
66.625M5.845M8.77%
Q3 2021
Q2Q % growth
64.84M
54.93%
56.765M8.075M14.23%
Q2 2021
Q2Q % growth
84.68M
104.44%
71.901M12.779M17.77%
Q1 2021
Q2Q % growth
55.15M
66.31%
64.112M-8.962M-13.98%
Q4 2020
Q2Q % growth
69.99M 55.177M14.813M26.85%
Q3 2020
Q2Q % growth
41.85M 45.247M-3.397M-7.51%
Q2 2020
Q2Q % growth
41.42M 32.019M9.401M29.36%
Q1 2020
Q2Q % growth
33.16M 27.064M6.096M22.52%
LGND Yearly Revenue VS EstimatesLGND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS5.26% -23.81% -3.25% 6.52%
Revenue-0.24% -11.05% -2.41% 16.66%